医学
彭布罗利珠单抗
伦瓦提尼
子宫内膜癌
肿瘤科
内科学
癌症
妇科
作者
Vicky Makker,Nicoletta Colombo,Antonio Casado Herráez,Alessandro D. Santin,Emeline Colomba,David S. Miller,Keiichi Fujiwara,Sandro Pignata,Sally Baron-Hay,Isabelle Ray-Coquard,Ronnie Shapira-Frommer,Kimio Ushijima,Jun Sakata,Kan Yonemori,Yong Man Kim,Eva M. Guerra,Ulus A. Sanli,Mary M. McCormack,Alan D. Smith,Stephen Keefe
标识
DOI：10.1056/nejmoa2108330
摘要
Lenvatinib plus pembrolizumab led to significantly longer progression-free survival and overall survival than chemotherapy among patients with advanced endometrial cancer. (Funded by Eisai and Merck Sharp and Dohme [a subsidiary of Merck]; Study 309-KEYNOTE-775 ClinicalTrials.gov number, NCT03517449.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
可耐的豪英
嘻嘻哈哈
Criminology34
SimpleKwee
无极微光
张欢馨
不能玩一下午吗
欢呼洋葱
Momomo
平常千万
自然思烟
ponymjj
Untitled
Yyyyyyyyy
竹筏过海
毛豆爸爸
OsamaKareem
慕青
愔愔
皖公网安备34019202002308
